Bonner Michael 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 22, 2019
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2019-03-22$5.62/sh+1,033$5,805→ 19,921 total - Award
Common Stock
2019-03-22$5.98/sh+2,500$14,950→ 20,954 total
Footnotes (2)
- [F1]Restricted stock award will vest 100% on March 18, 2023.
- [F2]This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of shares.